A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia - Aref Al‐Kali; Ibrahim Aldoss; Pamela J. Atherton; Carrie A. Strand; Bijal Shah; Jonathan Webster; Bhavana Bhatnagar; Karen S. Flatten; Kevin L. Peterson; Paula A. Schneider; Sarah A. Buhrow; Jianping Kong; et al. (Cancer Medicine, 2023)